Advances in mitochondria-targeted nanoparticles for lung cancer therapy
Lung cancer is one of the most commonly diagnosed and lethal malignancies worldwide. Although multimodal treatment has advanced substantially, therapeutic resistance, recurrence, and metastasis remain major clinical challenges.